HomeBCLI • OTCMKTS
Brainstorm Cell Therapeutics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.57M | -13.72% |
Net income | -2.90M | -14.25% |
Net profit margin | — | — |
Earnings per share | -0.34 | 43.33% |
EBITDA | -2.52M | 13.57% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 824.00K | -76.25% |
Total assets | 2.57M | -54.85% |
Total liabilities | 8.62M | -6.37% |
Total equity | -6.06M | — |
Shares outstanding | 10.38M | — |
Price to book | -1.08 | — |
Return on assets | -209.63% | — |
Return on capital | 115.21% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.90M | -14.25% |
Cash from operations | -3.50M | -108.08% |
Cash from investing | — | — |
Cash from financing | 2.70M | -38.19% |
Net change in cash | -801.00K | -129.81% |
Free cash flow | -2.48M | -319.02% |
Previous close
$0.65
Day range
$0.61 - $0.69
Year range
$0.52 - $5.72
Market cap
6.38M USD
Avg Volume
251.13K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
About
Founded
2000
Website
Employees
29
